Health systems need a better way to deliver cancer screening.
Too many eligible patients remain unscreened despite a growing list of cancer screening options. Freenome is partnering with health systems to build a more personalized and connected approach to screening.
Health systems need a better way to deliver cancer screening.
Be at the forefront
of a new cancer
screening paradigm
Transform how your patients get screened with a single blood draw and digital tools. Freenome’s health system solution integrates testing and workflows to help close the gap in cancer screening.
Be at the forefront
of a new cancer
screening paradigm
Transform how your patients get screened with a single blood draw and digital tools. Freenome’s health system solution integrates testing and workflows to help close the gap in cancer screening.
Be at the forefront
of a new cancer
screening paradigm
Expand participation. Build for what's next.
Personalized screening. Connected care.
Personalized Cancer Detection
Freenome's approach to blood-based cancer screening combines risk-based screening with indication-specific tests, all through a simple blood draw.
Freenome
Digital Health
EHR-native digital tools that help health systems identify eligible patients, engage patients and care teams, and integrate screening into routine care.
What this means for health systems
Help shape what's next in cancer screening
What you'll receive as a Founding Partner
Program Design and Optimization
Evidence Generation
Expanding Portfolio
Shape What’s Next
Explore the Founding Partner Guide
Ready to help shape what’s next?
1. NORC at the University of Chicago. (2022). Percent of Cancers Detected by Screening in the U.S. Available at https://cancerdetection.norc.org
2. Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10-45. doi:10.3322/caac.21871